Report Detail
Global (United States, European Union and China) Sophocarpidine (CAS：519-02-8) Market Research Report 2019-2025
- RnM3578645 |
- 22 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.
In 2019, the market size of Sophocarpidine (CAS：519-02-8) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sophocarpidine (CAS：519-02-8).
This report studies the global market size of Sophocarpidine (CAS：519-02-8), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Sophocarpidine (CAS：519-02-8) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Fujie Pharmaceutical
QHL Pharma
Select Botanical
Indena
Qinghai Lake Pharmaceuticals
TIANSHAN Pharmaceuticals
Selco Wirkstoffe Vertriebs GmbH
Jiangsu Tiansheng Pharmaceutical
Tiansheng Pharmaceutical
Hubei Zhongliao Chemical Co., LTD
Market Segment by Product Type
High Purity
Low Purity
Market Segment by Application
Pharmaceuticals
Pesticides
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Sophocarpidine (CAS：519-02-8) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Sophocarpidine (CAS：519-02-8) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Sophocarpidine (CAS：519-02-8) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Sophocarpidine (CAS：519-02-8) Market Size Growth Rate by Type (2019-2025)
- 1.3.2 High Purity
- 1.3.3 Low Purity
- 1.4 Market Segment by Application
- 1.4.1 Global Sophocarpidine (CAS：519-02-8) Market Share by Application (2019-2025)
- 1.4.2 Pharmaceuticals
- 1.4.3 Pesticides
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Sophocarpidine (CAS：519-02-8) Market Size
- 2.1.1 Global Sophocarpidine (CAS：519-02-8) Revenue 2014-2025
- 2.1.2 Global Sophocarpidine (CAS：519-02-8) Sales 2014-2025
- 2.2 Sophocarpidine (CAS：519-02-8) Growth Rate by Regions
- 2.2.1 Global Sophocarpidine (CAS：519-02-8) Sales by Regions 2014-2019
- 2.2.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Sophocarpidine (CAS：519-02-8) Sales by Manufacturers
- 3.1.1 Sophocarpidine (CAS：519-02-8) Sales by Manufacturers 2014-2019
- 3.1.2 Sophocarpidine (CAS：519-02-8) Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Sophocarpidine (CAS：519-02-8) Revenue by Manufacturers (2014-2019)
- 3.2.2 Sophocarpidine (CAS：519-02-8) Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Sophocarpidine (CAS：519-02-8) Market Concentration Ratio (CR5 and HHI)
- 3.3 Sophocarpidine (CAS：519-02-8) Price by Manufacturers
- 3.4 Key Manufacturers Sophocarpidine (CAS：519-02-8) Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Sophocarpidine (CAS：519-02-8) Market
- 3.6 Key Manufacturers Sophocarpidine (CAS：519-02-8) Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 High Purity Sales and Revenue (2014-2019)
- 4.1.2 Low Purity Sales and Revenue (2014-2019)
- 4.2 Global Sophocarpidine (CAS：519-02-8) Sales Market Share by Type
- 4.3 Global Sophocarpidine (CAS：519-02-8) Revenue Market Share by Type
- 4.4 Sophocarpidine (CAS：519-02-8) Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Sophocarpidine (CAS：519-02-8) Sales by Application
6 United States
- 6.1 United States Sophocarpidine (CAS：519-02-8) Breakdown Data by Company
- 6.2 United States Sophocarpidine (CAS：519-02-8) Breakdown Data by Type
- 6.3 United States Sophocarpidine (CAS：519-02-8) Breakdown Data by Application
7 European Union
- 7.1 European Union Sophocarpidine (CAS：519-02-8) Breakdown Data by Company
- 7.2 European Union Sophocarpidine (CAS：519-02-8) Breakdown Data by Type
- 7.3 European Union Sophocarpidine (CAS：519-02-8) Breakdown Data by Application
8 China
- 8.1 China Sophocarpidine (CAS：519-02-8) Breakdown Data by Company
- 8.2 China Sophocarpidine (CAS：519-02-8) Breakdown Data by Type
- 8.3 China Sophocarpidine (CAS：519-02-8) Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Sophocarpidine (CAS：519-02-8) Breakdown Data by Company
- 9.2 Rest of World Sophocarpidine (CAS：519-02-8) Breakdown Data by Type
- 9.3 Rest of World Sophocarpidine (CAS：519-02-8) Breakdown Data by Application
- 9.4 Rest of World Sophocarpidine (CAS：519-02-8) Breakdown Data by Countries
- 9.4.1 Rest of World Sophocarpidine (CAS：519-02-8) Sales by Countries
- 9.4.2 Rest of World Sophocarpidine (CAS：519-02-8) Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Fujie Pharmaceutical
- 10.1.1 Fujie Pharmaceutical Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.1.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.1.5 Fujie Pharmaceutical Recent Development
- 10.2 QHL Pharma
- 10.2.1 QHL Pharma Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.2.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.2.5 QHL Pharma Recent Development
- 10.3 Select Botanical
- 10.3.1 Select Botanical Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.3.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.3.5 Select Botanical Recent Development
- 10.4 Indena
- 10.4.1 Indena Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.4.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.4.5 Indena Recent Development
- 10.5 Qinghai Lake Pharmaceuticals
- 10.5.1 Qinghai Lake Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.5.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.5.5 Qinghai Lake Pharmaceuticals Recent Development
- 10.6 TIANSHAN Pharmaceuticals
- 10.6.1 TIANSHAN Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.6.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.6.5 TIANSHAN Pharmaceuticals Recent Development
- 10.7 Selco Wirkstoffe Vertriebs GmbH
- 10.7.1 Selco Wirkstoffe Vertriebs GmbH Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.7.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.7.5 Selco Wirkstoffe Vertriebs GmbH Recent Development
- 10.8 Jiangsu Tiansheng Pharmaceutical
- 10.8.1 Jiangsu Tiansheng Pharmaceutical Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.8.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.8.5 Jiangsu Tiansheng Pharmaceutical Recent Development
- 10.9 Tiansheng Pharmaceutical
- 10.9.1 Tiansheng Pharmaceutical Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.9.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.9.5 Tiansheng Pharmaceutical Recent Development
- 10.10 Hubei Zhongliao Chemical Co., LTD
- 10.10.1 Hubei Zhongliao Chemical Co., LTD Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Sophocarpidine (CAS：519-02-8)
- 10.10.4 Sophocarpidine (CAS：519-02-8) Product Introduction
- 10.10.5 Hubei Zhongliao Chemical Co., LTD Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Sophocarpidine (CAS：519-02-8) Sales Channels
- 11.2.2 Sophocarpidine (CAS：519-02-8) Distributors
- 11.3 Sophocarpidine (CAS：519-02-8) Customers
12 Market Forecast
- 12.1 Global Sophocarpidine (CAS：519-02-8) Sales and Revenue Forecast 2019-2025
- 12.2 Global Sophocarpidine (CAS：519-02-8) Sales Forecast by Type
- 12.3 Global Sophocarpidine (CAS：519-02-8) Sales Forecast by Application
- 12.4 Sophocarpidine (CAS：519-02-8) Forecast by Regions
- 12.4.1 Global Sophocarpidine (CAS：519-02-8) Sales Forecast by Regions 2019-2025
- 12.4.2 Global Sophocarpidine (CAS：519-02-8) Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Sophocarpidine (CAS：519-02-8). Industry analysis & Market Report on Sophocarpidine (CAS：519-02-8) is a syndicated market report, published as Global (United States, European Union and China) Sophocarpidine (CAS：519-02-8) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Sophocarpidine (CAS：519-02-8) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
